Moreover, as the expression of both IL-34 and M-CSF1-R in primary lung adenocarcinoma cells increases upon exposure to doxorubicin or cisplatin, IL-34 protein levels may also serve as a biomarker to monitor chemoresistance insurgence and progression in cancer patients receiving chemotherapy [36]. Here, IL34 is linked to lung adenocarcinoma.